Effect of Filgrastim on Serum Lactate Dehydrogenase and Alkaline Phosphatase Values in Early Breast Cancer Patients
Paola Papaldo(Cancer Institute (WIA)), F. Cognetti(Sapienza University of Rome), Paolo Carlini(National Cancer Institute), Alessandra Fabi(Agostino Gemelli University Polyclinic), Serena Di Cosimo(Fondazione IRCCS Istituto Nazionale dei Tumori), Paolo Marolla(Catholic University of America), G. Ferretti(Istituti di Ricovero e Cura a Carattere Scientifico), Patrizia Vici(Istituti di Ricovero e Cura a Carattere Scientifico)
Cited by 5
Related Papers
CEREBEL (EGF111438): A Phase III, Randomized, Open-Label Study of Lapatinib Plus Capecitabine Versus Trastuzumab Plus Capecitabine in Patients With Human Epidermal Growth Factor Receptor 2–Positive Metastatic Breast Cancer
|Journal of Clinical Oncology|2015|253
Fluorouracil and dose-dense chemotherapy in adjuvant treatment of patients with early-stage breast cancer: an open-label, 2 × 2 factorial, randomised phase 3 trial
|The Lancet|2015|202
Phase III randomized study of fluorouracil, epirubicin, and cyclophosphamide v fluorouracil, doxorubicin, and cyclophosphamide in advanced breast cancer: an Italian multicentre trial. Italian Multicentre Breast Study with Epirubicin.
|Journal of Clinical Oncology|1988|168
Lonidamine: Efficacy and safety in clinical trials for thetreatment of solid tumors
|Drugs of today|2003|168